Eva Pokorná

1.2k total citations
53 papers, 510 citations indexed

About

Eva Pokorná is a scholar working on Surgery, Transplantation and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Eva Pokorná has authored 53 papers receiving a total of 510 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Surgery, 14 papers in Transplantation and 12 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Eva Pokorná's work include Renal Transplantation Outcomes and Treatments (13 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Organ Donation and Transplantation (11 papers). Eva Pokorná is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Organ Donation and Transplantation (11 papers). Eva Pokorná collaborates with scholars based in Czechia, United Kingdom and Sweden. Eva Pokorná's co-authors include Š Vı́tko, Pavel Veselý, O Schück, Daniel Zicha, Pavel Klener, Petra Vočková, C. S. Gilbert, P. Jordan, Ondřej Viklický and C.H. O'Neill and has published in prestigious journals such as Circulation, Blood and PLoS ONE.

In The Last Decade

Eva Pokorná

46 papers receiving 501 citations

Peers

Eva Pokorná
Lynn O’Donnell United States
Vivek Kasinath United States
Ann McCormack United Kingdom
Chang‐Ki Min South Korea
John Boulas Australia
Eva Pokorná
Citations per year, relative to Eva Pokorná Eva Pokorná (= 1×) peers Maren Schulze

Countries citing papers authored by Eva Pokorná

Since Specialization
Citations

This map shows the geographic impact of Eva Pokorná's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Pokorná with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Pokorná more than expected).

Fields of papers citing papers by Eva Pokorná

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Pokorná. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Pokorná. The network helps show where Eva Pokorná may publish in the future.

Co-authorship network of co-authors of Eva Pokorná

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Pokorná. A scholar is included among the top collaborators of Eva Pokorná based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Pokorná. Eva Pokorná is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pola, Robert, Michal Pechar, Libor Kostka, et al.. (2025). Nanomedicines for Delivery of Cytarabine: Effect of Carrier Structure and Spacer on the Anti-Lymphoma Efficacy. Polymers. 17(21). 2837–2837.
2.
Filipová, Marcela, Petra Kovařı́ková, Jan Pankrác, et al.. (2025). Antibody polymer drug conjugates with increased drug to antibody ratio: CD38-targeting nanomedicines for innovative therapy of relapsed lymphomas. Journal of Controlled Release. 384. 113876–113876. 2 indexed citations
3.
Šmalcová, Jana, Eva Pokorná, Ondřej Franěk, et al.. (2024). Impact of routine extracorporeal cardiopulmonary resuscitation service on the availability of donor organs. The Journal of Heart and Lung Transplantation. 44(6). 872–879. 3 indexed citations
4.
Šmalcová, Jana, Štěpán Havránek, Eva Pokorná, et al.. (2023). Extracorporeal cardiopulmonary resuscitation-based approach to refractory out-of-hospital cardiac arrest: A focus on organ donation, a secondary analysis of a Prague OHCA randomized study. Resuscitation. 193. 109993–109993. 24 indexed citations
5.
Hubáček, Jaroslav A., Petra Hrubá, Věra Adámková, Eva Pokorná, & Ondřej Viklický. (2022). Apolipoprotein L1 variability is associated with increased risk of renal failure in the Czech population. Gene. 818. 146248–146248. 1 indexed citations
6.
Jakša, Radek, Michael Svatoň, Eva Pokorná, et al.. (2022). Complex genetic and histopathological study of 15 patient-derived xenografts of aggressive lymphomas. Laboratory Investigation. 102(9). 957–965. 5 indexed citations
7.
Vočková, Petra, et al.. (2020). Anti-CD38 Therapy with Daratumumab for Relapsed/Refractory CD20-Negative Diffuse Large B-Cell Lymphoma. Folia Biologica. 66(1). 17–23. 8 indexed citations
8.
Průková, Dana, Ladislav Anděra, Zuzana Nahácka, et al.. (2019). Cotargeting of BCL2 with Venetoclax and MCL1 with S63845 Is Synthetically Lethal In Vivo in Relapsed Mantle Cell Lymphoma. Clinical Cancer Research. 25(14). 4455–4465. 63 indexed citations
10.
Etrych, Tomáš, Eva Pokorná, Jan Pankrác, et al.. (2018). Effective doxorubicin-based nano-therapeutics for simultaneous malignant lymphoma treatment and lymphoma growth imaging. Journal of Controlled Release. 289. 44–55. 31 indexed citations
11.
Pokorná, Eva, et al.. (2017). Lack of Impact of Hyperchloremia in Brain-Dead Organ Donors on the Onset of Kidney Allograft Function in the Recipients. Transplantation Proceedings. 49(6). 1262–1269. 2 indexed citations
12.
Hubáček, Jaroslav A., Ondřej Viklický, Dana Dlouhá, et al.. (2011). The FTO gene polymorphism is associated with end-stage renal disease: two large independent case-control studies in a general population. Nephrology Dialysis Transplantation. 27(3). 1030–1035. 39 indexed citations
13.
Pokorná, Eva, et al.. (2005). Immune Characterization of the Lewis Rats Inoculated with K2 Sarcoma Cell Line and Newly Derived R5-28 Malignant Cells. Folia Biologica. 51(6). 159–165. 5 indexed citations
14.
Pokorná, Eva, et al.. (2003). Two Dynamic Morphotypes of Sarcoma Cells, Asymmetric Stellate and Triangle with Leading Lamella, are Related to Malignancy. Folia Biologica. 49(1). 33–39. 5 indexed citations
15.
Veselý, Pavel, et al.. (2002). Large expansion of morphologically heterogeneous mammary epithelial cells, including the luminal phenotype, from human breast tumours. Breast Cancer Research and Treatment. 71(3). 219–235. 14 indexed citations
16.
Pokorná, Eva, O Schück, Š Vı́tko, & Henrik Ekberg. (2002). Estimated and Measured Donor Creatinine Clearance are Poor Predictors of Long-Term Renal Graft Function and Survival. American Journal of Transplantation. 2(4). 373–380. 12 indexed citations
17.
Matoušková, Eva, L Brož, Eva Pokorná, & R Königová. (2002). Prevention of burn wound conversion by allogeneic keratinocytes cultured on acellular xenodermis. Cell and Tissue Banking. 3(1). 29–35. 9 indexed citations
18.
Pokorná, Eva, et al.. (2000). Compliance with kidney allocation criteria in the czech republic in 1997. Transplantation Proceedings. 32(1). 91–93. 1 indexed citations
19.
Pokorná, Eva, et al.. (1997). Survival and function of a renal graft from a marginal cadaver donor. Transplantation Proceedings. 29(1-2). 118–121. 4 indexed citations
20.
Pokorná, Eva, P. Jordan, C.H. O'Neill, et al.. (1994). Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motility and the Cytoskeleton. 28(1). 25–33. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026